Search research articles
Contact Us
Filters
Showing results (181-190 of 2,139) with videos related to
Page
of 214
Sort By:
Current Atherosclerosis Reports
|
March 27, 2021
The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes
W Sean Davidson, Allison L Cooke, Debi K Swertfeger, et al.
Current Atherosclerosis Reports
|
April 1, 2021
How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
Trevor D Hadley, Ali M Agha, Christie M Ballantyne
Current Atherosclerosis Reports
|
March 17, 2015
Nuclear receptors in vascular biology
David Bishop-Bailey
Current Atherosclerosis Reports
|
March 28, 2015
Fibroblast growth factor signaling in the vasculature
Xuehui Yang, Lucy Liaw, Igor Prudovsky, et al.
Current Atherosclerosis Reports
|
February 19, 2015
The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines?
Laura Flink, James A Underberg, Jonathan D Newman, et al.
Current Atherosclerosis Reports
|
February 19, 2015
Shared genetic aetiology of coronary artery disease and atherosclerotic stroke - 2015
Thorsten Kessler, Jeanette Erdmann, Martin Dichgans, et al.
Current Atherosclerosis Reports
|
April 22, 2023
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference
Kartik Gupta, Isabel Balachandran, Jacob Foy, et al.
Current Atherosclerosis Reports
|
January 5, 2002
Peroxisome proliferator-activated receptors
Ouliana Ziouzenkova, Stephane Perrey, Niko Marx, et al.
Current Atherosclerosis Reports
|
January 5, 2002
Gut-acting drugs for lowering cholesterol
Donald M Black
Current Atherosclerosis Reports
|
August 7, 2002
Clinical implications of statin event trials
Anne Carol Goldberg
Page
of 214
Search research articles
Search
Showing results (181-190 of 2,139) with videos related to
Sort By:
Page
of 214
Current Atherosclerosis Reports
|
March 27, 2021
The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes
W Sean Davidson, Allison L Cooke, Debi K Swertfeger, et al.
Current Atherosclerosis Reports
|
April 1, 2021
How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
Trevor D Hadley, Ali M Agha, Christie M Ballantyne
Current Atherosclerosis Reports
|
March 17, 2015
Nuclear receptors in vascular biology
David Bishop-Bailey
Current Atherosclerosis Reports
|
March 28, 2015
Fibroblast growth factor signaling in the vasculature
Xuehui Yang, Lucy Liaw, Igor Prudovsky, et al.
Current Atherosclerosis Reports
|
February 19, 2015
The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines?
Laura Flink, James A Underberg, Jonathan D Newman, et al.
Current Atherosclerosis Reports
|
February 19, 2015
Shared genetic aetiology of coronary artery disease and atherosclerotic stroke - 2015
Thorsten Kessler, Jeanette Erdmann, Martin Dichgans, et al.
Current Atherosclerosis Reports
|
April 22, 2023
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference
Kartik Gupta, Isabel Balachandran, Jacob Foy, et al.
Current Atherosclerosis Reports
|
January 5, 2002
Peroxisome proliferator-activated receptors
Ouliana Ziouzenkova, Stephane Perrey, Niko Marx, et al.
Current Atherosclerosis Reports
|
January 5, 2002
Gut-acting drugs for lowering cholesterol
Donald M Black
Current Atherosclerosis Reports
|
August 7, 2002
Clinical implications of statin event trials
Anne Carol Goldberg
Page
of 214